Document is current
Any future updates will be listed below
-
Authors
Ribero, Dario
Aprile, Giuseppe
- License Information
-
More Information
Article History
Received: 11 March 2022
Accepted: 26 March 2022
First Online: 27 May 2022
Disclosure
: Giuseppe Aprile has received speakers’ fees from Amgen, Eli Lilly, BMS, MSD, Novartis, Astellas, and Ipsen. Dario Ribero has no conflicts of interest to declare.
